Item 10 of 14

“= Question 95

41 Pe

Previous Next Tutorial

Selective estrogen receptor modulators

Drugs

Tamoxifen
Raloxifene

Mechanism of action

Competitive inhibitor of estrogen binding
Mixed agonist/antagonist action

Indications

Prevention of breast cancer in high-risk patients
Tamoxifen: adjuvant treatment of breast cancer
Raloxifene: postmenopausal osteoporosis

Adverse effects

Hot flashes

Venous thromboembolism

Endometrial hyperplasia & carcinoma (tamoxifen only)
Uterine sarcoma (tamoxifen only)

This patient has amenorrhea and low bone density, suggesting a low-estrogen state. This may

be due to menopause, although her exercise history suggests possible hypothalamic

amenorrhea (excessive exercise suppresses secretion of GnRH, leading to decreased release

é

Lab Values

Text Zoom

Settings

pend

End Block
